Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of Moderate Buy by Analysts

Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The […]

Related Keywords

United States ,Canada ,America ,Richardf Wallman ,Asia Pacific ,Jamesc Foster ,Covestor Ltd ,Charles River Laboratories International Inc ,Lindbrook Capital ,Desjardins Global Asset Management Inc ,Venturi Wealth Management ,Wells Fargo Company ,Research Models ,Charles River Laboratories International Stock ,Analyst Recommendations For Charles River Laboratories International ,Manufacturing Solutions ,Securities Exchange Commission ,Charles River Laboratories International ,Get Free Report ,Director Richard ,Exchange Commission ,Wealth Management ,Global Asset Management ,River Laboratories International ,Get Free ,Safety Assessment ,Charles River Laboratories International Daily ,Nyse Crl ,Crl ,Medical ,15986410 ,Ratings ,Consensus ,